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Background: Type 2 diabetes mellitus (T2DM) is often associated with atherosclerotic changes in coronary vessels,
most notably plaques. The angiostatic parameter endostatin is able to inhibit angiogenesis in tissue as well as in
plaques and therefore plays an important role in physiological and pathological neovascularisation. The aim of the
present study was to investigate sex-specific differences and the influence of exercise on circulating endostatin
levels in patients suffering from diabetes, and control subjects.
Methods: In total, 42 T2DM-patients and 45 control subjects were investigated. They underwent a graded physical
stress test (ergometry). Serum endostatin levels were measured in venous blood at rest and directly after reaching
maximum workload.
Results: Females showed significantly higher endostatin levels at baseline measurements compared to men,
independently of their underlying disease. In both female and male T2DM-patients endostatin levels were
significantly lower compared to controls. Both groups and sexes showed a significant increase of endostatin after
physical stress, whereas the extent of endostatin-increase was between 10.59-15.05%.
Conclusion: Middle-aged healthy female individuals as well as female T2DM-patients showed higher circulating
serum endostatin levels compared to males, suggesting a hormonal influence on baseline circulating endostatin
amounts. Exercise-induced increase in endostatin is also observable in patients suffering from T2DM. Concerning
vascularisation, lower endostatin levels in T2DM might be advantageous. Concerning plaque stability, lower levels
might be prejudicial.
Trial registration: Clinical Trial Registration-URL: http://clinicaltrials.gov/ct2/results?term=NCT01165515
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Diabetes mellitus (T2DM) is one of the most important
risk factors for cardiovascular diseases and strokes in in-
dustrialized as well as emergent countries. Men suffering
from T2DM have about a 2-fold to 3-fold increased risk of
developing coronary heart disease, whereas diabetic
women develop a 3-fold to 7-fold risk for cardiovascular
events [1]. As Mascarenhas-Melo et al. showed T2DM ab-
rogates the protective effect of gender on non-diabetic
women [2]. Due to the “AHA Classification of CVD Risk* Correspondence: michael.sponder@meduniwien.ac.at
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stated.in Women”, the presence of T2DM, as a single risk factor,
is sufficient to classify a woman as a “high risk of CVD”-
patient [3]. T2DM induces impaired production and bio-
availability of nitric oxygen (NO) leading to endothelial
dysfunction promoting inflammation and subsequent
atherosclerosis.
Endostatin, a heparane sulphate proteoglycan [4], com-
prising non-collagenous and collagenous domains [5,6], is
a component of nearly all epithelial and endothelial base-
ment membranes in the human body. It turned out to be
a strong angiogenesis modulator with angiostatic effects
by inhibiting proliferation [7], (VEGF-induced) migration
[8] and adhesion [9] of endothelial cells and tube forma-
tion [10] leading to reduced angiogenesis.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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the process of atherosclerosis in respect to its main
manifestations [11-14]. Physical exercise, on a regular
basis, promotes angiogenesis in the skeletal muscle due
to the increased physical requirements [15]. Gu. et al.,
were the first to show an exercise-induced increase of
endostatin in healthy subjects [16]. These findings were
confirmed by Rullman et al. [17] and Suhr et al. [18]. In
a further study by Gu et al., where 7 healthy male sub-
jects who performed treadmill exercise for 4–10 minutes,
showed plasma endostatin levels increased significantly.
Over 30 minutes (43%), over 2 hours (73%) and 6 hours
(33%) compared to baseline levels [19]. Exercise-induced
increase of serum endostatin levels were also observed
by Suhr et al. in short- and long-track elite runners [20].
Further to these studies, Brixius et al. observed a de-
crease in plasma endostatin levels in obese men follow-
ing a 6-month training period. However, in all these
studies only small populations of male subjects were in-
vestigated, so there remains a significant lack of data for
endostatin in females.
Therefore, the primary aim of the current study was to
investigate the effect of graded bicycle exercise on endo-
statin levels in middle-aged patients suffering from dia-
betes mellitus compared to a sex-and age-matched
control group under a sex-specific perspective.
Material and methods
Included subjects
All 87 subjects were recruited at the Medical University
of Vienna, had to be between 35–80 years of age, never-
smokers, sparsely to moderately active (<150 min. of
moderate physical exercise per week) and able to per-
form a bicycle stress test. Exclusion criteria for both
groups were the presence of current infectious disease,
anamnestic CAD (coronary artery disease) or COPD
(chronic obstructive pulmonary disease). Within the
control group (21 females, 24 males) only subjects not
taking medication were recruited. Individuals of the
T2DM-group were recruited at the outpatient clinic of
the Medical University of Vienna and consisted of 22
female and 20 male patients suffering T2DM for at least
5 years with a HbA1c >7% (in the course of the last
check). The study was approved by the Ethical Committee
of the Medical University of Vienna and all subjects pro-
vided written informed consent prior to participation.
Bicycle stress testing
All ergometry tests were done in the early afternoon.
After physical examination and a 30-minute period of
rest, a needle was inserted in an anticubital vein and all
included subjects had to undergo a 12-lead-ECG-con-
trolled graded bicycle exercise test according to the
ergometry protocol of the Austrian Society of Cardiologywhich is consistent with the protocol of the The German
Society of Cardiology and the Bruce Protocol [21]. The
participants were asked to reach their individual max-
imum workload (calculated by age, sex, height and
weight) until exhaustion occured, where the workload
increased every 2 minutes by 25 watts. Subjects were
under permanent ECG-monitoring and blood pressure
was taken at rest and every 2 minutes.
Laboratory analysis
Subjects had to rest for 20 minutes in a quiet, peaceful
room before the first blood samples were taken, to prevent
any physical effort influencing endostatin baseline levels.
Blood samples were taken through a venous winged infu-
sion set prior to bicycle stress testing (baseline levels) and
directly after reaching the maximum workload (stress
levels). Blood samples were collected in 8 ml Z serum sep
Clot-activator tubes with separating gel for the determin-
ation of endostatin. Samples were analysed with Quanti-
kine® Human Endostatin Sandwich Enzyme Immunoassay
(R&D System Inc. Minneapolis, USA).
Statistical analysis
Statistical analysis was performed using the statistical
software SPSS 20.0. Continuous and normally distrib-
uted data was described by means ± standard deviation
(SD) and group differences were tested by independent
sample t-test. The significance of the difference between
baseline and stress endostatin was tested by paired sam-
ple t-test. All tests were performed two-sided and p ≤
0.05 was considered significant.
Results
Basic demographic data including the number of subjects,
mean age (years), mean BMI (kg/m2), mean heart rate
(bpm) and mean basic systolic and diastolic blood pressure
(mmHg) are shown in Table 1. Although T2DM-patients
were slightly older and had a higher BMI compared to the
controls the differences were not significant. The same
holds true for heart rate and blood pressure.
Routine laboratory parameters are shown in Table 2.
As expected, both female and male T2DM-patients had
higher glucose levels compared to controls. T2DM-
patients showed lower total cholesterol, LDL-cholesterol
and triglyceride levels but also lower HDL-cholesterol
levels.
Endostatin levels, at baseline and at maximum work-
load, as well as the extent to which endostatin increases
immediately after the bicycle stress tests are shown in
Table 3. At baseline the highest levels were shown by fe-
male control subjects and T2DM-patients (167.70 ±
18.19 vs. 145.50 ± 33.14 ng/ml; p = 0.022) followed by
male controls and T2DM-patients (118.56 ± 16.41 vs.
136.40 ± 15.16 ng/ml; p = 0.031). Female T2DM-patients
Table 1 Anthropometric data, heart rate and blood pressure
Table 1 Female T2DM (n = 22) Female control (n = 21) p-value Male T2DM (n = 20) Male control (n = 24) p-value
Age (years) 59.45 ± 9.12 58.62 ± 6.48 0.732 57.21 ± 7.80 52.80 ± 6.69 0.053
BMI (kg/m2) 27.51 ± 4.79 23.85 ± 3.58 0.054 30.12 ± 6.37 27.05 ± 2.69 0.051
Heart rate (bpm) 77.42 ± 11.69 74.44 ± 10.83 0.442 77.70 ± 11.70 69.75 ± 10.97 0.033
Systoly (mmHg) 132.00 ± 8.73 127.81 ± 10.80 0.213 132.20 ± 18.00 127.20 ± 10.24 0.287
Diastoly (mmHg) 82.89 ± 9.02 80.96 ± 8.36 0.462 81.60 ± 10.81 75.95 ± 6.56 0.053
Table 1: Anthropometric data, heart rate and blood pressure: Age, BMI, heart rate, systolic and diastolic blood pressure of T2DM-patients and controls. P-values
show the statistical sex-specific differences between female T2DM patients and controls and male T2DM patients and controls resp. Data is presented
as mean ± SD.
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pared to male T2DM-patients (p < 0.001) and the same
was observable for the control group (p < 0.001).
Standardized physical performance (%) during bicycle
stress testing was calculated on a basis of age, sex, height
and weight. Female T2DM-patients as well as male patients
reached much lower performance levels compared to fe-
male and male controls (59.55 ± 11.06%/68.86 ± 13.31% vs.
105.95 ± 22.28%/97.89 ± 7.14%). Nevertheless, bicycle stress
testing was associated with a significant increase in endo-
statin levels in both groups and sexes (p < 0.001-0.001).
The highest increase was found in male controls (15.05%)
followed by male T2DM-patients (11.87%), female T2DM-
patients (11.52%) and female controls (10.59%). Although
there were significant differences in performance, observ-
able Pearson Correlation analysis showed no correlation
between performance and basic (p = 0.110-0.841) or stress
endostatin levels (p = 0.058-0.693).
Discussion
It is well known that angiogenic factors such as VEGF play
an important role in patients suffering atherosclerosis and
diabetes [22] and might even be used as therapeuticTable 2 Routine laboratory parameters
Table 2 Female T2DM (n = 22) Female control (n =
Na+ 139.24 ± 2.88 139.56 ± 2.00
K+ 4.59 ± 0.47 4.23 ± 0.13
Glucose (mg/dl) 141.82 ± 43.77 93.44 ± 15.85
Creatinin (mg/dl) 0.96 ± 0.17 0.87 ± 0.10
Erythrocytes (T/l) 4.63 ± 0.41 4.46 ± 0.21
Thrombocytes (G/l) 247.84 ± 83.36 244.75 ± 39.99
Leucocytes (G/l) 7.21 ± 1.99 6.31 ± 1.26
Haemoglobin (g/dl) 13.17 ± 1.31 12.96 ± 0.88
Hematocrit (%) 39.41 ± 3.47 38.22 ± 2.35
Total cholesterol (mg/dl) 197.95 ± 33.47 224.69 ± 45.13
HDL-cholesterol (md/dl) 54.78 ± 9.49 72.50 ± 17.61
LDL-cholesterol (mg/dl) 104.92 ± 26.73 125.94 ± 38.96
Triglycerides (mg/dl) 171.56 ± 72.70 131.25 ± 46.90
Table 2: Routine laboratory parameters of T2DM-patients and controls. P-values sho
controls and male T2DM patients and controls resp. Data is presented as mean ± SDtargets [23]. Endostatin is suggested to be a modulator of
angiogenesis with angiostatic effects and therefore a target
in therapies for cancer and cardiovascular disease. The
aim of the present study was to investigate baseline levels
and the influence of physical exercise on serum endostatin
levels in patients suffering from T2DM compared to con-
trols. We could show for the first time that endostatin
baseline levels, measured in serum, are decreased in pa-
tients suffering from T2DM compared to age- and sex-
matched healthy controls. With regard to the findings by
Boodhwani et al., [24] who showed that T2DM results in a
profound impairment in the myocardial angiogenic
response to chronic ischemia, these observations are of
distinct interest. Additionally, we stated a significant
exercise-induced increase in endostatin levels in T2DM
patients as well as in healthy controls.
Our first study aim was to investigate the influence of
acute exercise in T2DM-patients and controls. Bruserud
et al. observed higher serum baseline levels of endostatin
in 68–88 year old female and male people than in 18
year old male athletes and an increase in endostatin
levels after physical exercise [25]. An exercise-induced
increase in endostatin levels was also observed by Suhr21) p-value Male T2DM (n = 20) Male control (n = 24) p-value
0.703 138.70 ± 2.79 139.15 ± 1.39 0.513
0.531 4.60 ± 0.31 4.15 ± 0.27 <0.001
<0.001 140.27 ± 17.88 93.41 ± 7.46 <0.001
0.083 0.96 ± 0.15 0.96 ± 0.97 0.912
0.127 4.82 ± 0.36 4.83 ± 0.38 0.013
0.893 219.83 ± 34.35 221.55 ± 45.49 0.897
0.130 6.75 ± 1.26 5.95 ± 1.60 0.099
0.577 14.36 ± 1.07 14.56 ± 0.93 0.474
0.251 41.63 ± 2.99 42.86 ± 2,50 0.179
0.053 186.26 ± 43.56 230.45 ± 24.43 0.001
0.002 43.61 ± 5.95 54.90 ± 8.28 <0.001
0.073 107.56 ± 37.92 143.41 ± 19.28 0.001
0.065 163.92 ± 55.32 174.69 ± 74.12 0.612
w the statistical sex-specific differences between female T2DM patients and
.
Table 3 Endostatin at baseline and after bicycle stress testing
Table 3 Female T2DM (n = 22) Female control (n = 21) p-value Male T2DM (n = 20) Male control (n = 24) p-value
Baseline endostatin (ng/ml) 145.50 ± 33.14 167.70 ± 18.19 0.022 106.77 ± 16.86 118.56 ± 16.41 0.031
Stress endostatin (ng/ml) 162.26 ± 37.25 185.46 ± 17.96 0.021 119.44 ± 15.16 136.40 ± 15.16 0.001
Increase in endostatin -
ng/ml 16.76 17.76 12.67 17.84
% 11.52 10.60 11.87 15.05
p-value <0.001 <0.001 <0.001 0.001
Table 3: Endostatin levels at baseline and right after reaching maximum workload (stress) of T2DM-patients and controls. P-values show the statistical sex-specific
differences between female T2DM patients and controls and male T2DM patients and controls resp. Data is presented as mean ± SD.
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twelve male cyclists ages 27.8 ± 5.4 years [18] and in
short- and long-track elite runners [20]. Similar results
were delivered by Gu et al. who measured plasma endosta-
tin levels in seven healthy male subjects aged 18–49 years.
Gu et al. [19] could show in a rat model (Sprague–Dawley
rats), that continuous exercise leads to an decrease in
endostatin levels (measured in tissue of skeletal muscle).
Brixius et al. stated a decrease of endostatin plasma levels
in 50–60 year old male overweight and untrained men
after 6 months of moderate exercise 3 times/week [26].
However, Makey et al. [27] did not find an exercise-
induced increase of endostatin in overweight/obese
women, but in this study the participants “only” walked on
a treadmill at moderate intensity. Nevertheless, consider-
ing the results of the mentioned studies both unique and
regular physical exercise seems to have an impact on
endostatin levels in healthy individuals, where endostatin
seems to increase during exercise and to decrease after
regular sportive activity. Our results support the theory of
exercise-induced endostatin increase which was observ-
able in controls as well as in patients suffering from
T2DM. Although exercise-induced stress led to a signifi-
cant rise in endostatin in both groups it should be men-
tioned that male controls showed the highest surge by
15% whereas female controls and T2DM-patients only in-
creased by about 10–12%. Furthermore, the increase in
endostatin did not seem to be connected to the extent of
physical workload: Our subjects were asked to proceed
with the bicycle stress test till exhaustion. Although
T2DM-patients showed significantly lower performance
compared to controls, there was no correlation observable
between the extent of endostatin-increase, stress levels of
endostatin and performance (Pearson Correlation).
Our second aim was to investigate baseline endostatin
levels of T2DM-patients compared to controls with re-
gard to sex-specific differences. Boodhwani et al. [28]
measured 3,6-fold higher endostatin levels (myocardium)
in Yucatan miniswine compared to controls. Sodha et al.
[29] was able to show that endostatin levels are elevated
2,02-fold in diabetic patients with CAD in myocardial
tissue and that their levels showed a positive correlationto blood glucose levels. Interestingly, we found
significantly lower levels in both female and male pa-
tients suffering T2DM compare to controls. Additionally,
female controls showed significantly higher levels com-
pared to male controls suggesting a hormonal influence
on endostatin levels. These two findings are of distinct
interest.
On the one hand atherosclerotic vessels often present
intra-plaque angiogenesis [30], supporting plaque expan-
sion and leading to plaque rupture by enhancing its vul-
nerability [31,32]. Due to its angiostatic potential,
endostatin might enable plaque stabilization by inhibit-
ing sprouting and ingrowth of new vessels into the
plaque reducing plaque neovascularisation [33,34] and
therefore could reduce CVD progression. Furthermore,
Wenzel et al. recently were able to show, in vitro, that
endostatin reduces the vascular tonus by increasing the
production of NO by endothelial cells [35]. Following
this chain of thought, individuals with high levels of
endostatin would be protected more effectively from
CVD progression and would have more NO available.
On the other hand, Gu et al. [19] showed in rats that
high endostatin levels correlate with low capillary dens-
ity. Similar results were obtained from Sodha et al. [29]
who found elevated endostatin levels in the myocardial
tissue of diabetic patients together with a strong negative
correlation to coronary collateralization. As an organ
with a high metabolic demand meaning a high oxidative
capacity, the myocardium is dependent on a pronounced
capillary network. In this case, high endostatin levels
would be prejudicial because impaired collateralization
is one of the most important problems in T2DM, in par-
ticular in T2DM-patients with coronary artery disease.
With regard to our results and those of the mentioned
studies, it is now quite safe to assume that acute exercise
leads to an increase in endostatin in healthy individuals
and also T2DM-patients nearly to the same extent. Al-
though some studies found increased amounts in ani-
mals and patients suffering from T2DM, out data do not
support this thesis. To our knowledge, the present study
is the first one showing an exercise-induced surge in
serum endostatin also in T2DM-patients and a sex-
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male T2DM-patients and controls showing higher levels
than male individuals.
Endostatin levels seem to be dependent on a great num-
ber of factors such as sex, age, race, underlying diseases,
level of physical fitness and many more. Additionally, the
medium in which endostatin is analysed (serum, plasma,
muscle tissue, myocardial tissue, arterial, venous…) seems
to be of importance in determining its scope of action.
Further studies with higher numbers of participants are
needed to 1) investigate the influence of regular physical
exercise on endostatin release and 2) study the role of
endostatin in diabetes. At the present time it seems that
endostatin is involved in various mechanisms dealing with
angiogenesis and therefore it would be advisable to regard
it as modifier of angiogenesis with possible influence in
both physiological and pathological angiogenesis.
Conclusion
This is the first study showing an exercise-induced increase
in patients suffering T2DM. There seems to be a sex-
specific difference in baseline endostatin levels: Healthy fe-
male individuals as well as female T2DM-patients showed
higher circulating serum endostatin levels compared to
males. However, the reason for this sex-specific difference
remains unclear but might be caused by hormonal reasons.
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